1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Allergan, Inc. - Medical Equipment - Deals and Alliances Profile, Global Data

Summary

Allergan, Inc. (Allergan) is a global healthcare company. It develops and commercializes novel pharmaceuticals, over-the-counter products, biologics and the medical devices addressing ophthalmic, neurological, medical aesthetic, medical dermatology, breast aesthetic, urological, and other specialty markets. The company’s research and development efforts focus on products and technologies related to wide range of specialty areas with significant unmet clinical needs. The company sells its products through a network of own distributors and direct subsidiaries in approximately 40 countries and through independent distributors in about 100 countries across the world. The major customers of the company include wholesalers, drug stores, pharmacies, opticians, merchandisers, food stores, hospitals, and medical practitioners among others. Allergan is a subsidiary of Allergan Plc and is headquartered in Irvine, California, the US.

Allergan, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Allergan, Inc. - Medical Equipment - Deals and Alliances Profile, Global Data
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Allergan, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Allergan, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Allergan, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Allergan, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Allergan, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Allergan, Inc., Medical Equipment, Deal Details 11
Asset Purchase 11
Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics 11
Allergan Acquires Distribution Business In Turkey For US$36.7 Million 12
Venture Financing 13
Colorescience Raises USD15 Million in Series B Venture Financing 13
Colorescience Raises US$10 Million In Series A Financing 14
Colorescience Raises US$15 Million In Venture Financing 16
Private Equity 17
VMG Partners Invests In Colorescience 17
Debt Offering 18
Allergan Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$650 Million 18
Asset Transactions 20
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 20
Acquisition 22
Actavis Acquires Allergan for USD70.5 Billion 22
SkinMedica Acquires Colorescience, Maker Of Skincare Products 24
Allergan Acquires Precision Light For US$17.9 Million 25
Allergan Completes Acquisition Of Alacer Biomedical 26
Allergan Completes Acquisition Of Serica Technologies 27
Allergan, Inc. - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Other Locations and Subsidiaries 31
Recent Developments 35
Product News 35
Jun 04, 2015: Actavis Announces FDA Approval of NATRELLE INSPIRA Round Gel-Filled Textured Breast Implants 35
Apr 29, 2015: Allergan Selects ImageIQ as Imaging CRO for LiRIS Interstitial Cystitis Clinical Trial 36
Jan 30, 2015: Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold 37
Product Approvals 38
Jun 04, 2015: Actavis Announces FDA Approval of NATRELLE INSPIRA Round Gel-Filled Textured Breast Implants 38
Clinical Trials 39
Jan 30, 2015: Clinical Study: Improved Breast Reconstruction Outcomes with Seri Scaffold 39
Other Significant Developments 40
Sep 17, 2015: Berks County Plastic Surgery Practice Now Offering INSPIRA Breast Implants 40
Feb 04, 2015: Allergan Reports Fourth Quarter 2014 Operating Results 41
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Allergan, Inc., Medical Equipment, Key Facts, 2014 1
Allergan, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Allergan, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Allergan, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Allergan, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Allergan, Inc., Deals By Market, 2010 to YTD 2016 9
Allergan, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Allergan Acquires Aline Hyaluronic Acid Thread Technology From Aline Aesthetics 11
Allergan Acquires Distribution Business In Turkey For US$36.7 Million 12
Colorescience Raises USD15 Million in Series B Venture Financing 13
Colorescience Raises US$10 Million In Series A Financing 14
Colorescience Raises US$15 Million In Venture Financing 16
VMG Partners Invests In Colorescience 17
Allergan Completes Public Offering Of Senior Unsecured Notes Due 2020 For US$650 Million 18
Apollo Endosurgery Completes Acquisition Of Obesity Intervention Division Of Allergan For Up To US$110 Million 20
Actavis Acquires Allergan for USD70.5 Billion 22
SkinMedica Acquires Colorescience, Maker Of Skincare Products 24
Allergan Acquires Precision Light For US$17.9 Million 25
Allergan Completes Acquisition Of Alacer Biomedical 26
Allergan Completes Acquisition Of Serica Technologies 27
Allergan, Inc., Key Competitors 29
Allergan, Inc., Key Employees 30
Allergan, Inc., Other Locations 31
Allergan, Inc., Subsidiaries 31

List of Figures
Allergan, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Allergan, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Allergan, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Allergan, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Allergan, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Allergan, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Allergan, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Allergan, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 9

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016

Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • April 2016
  • by Global Markets Direct

Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Glucose-Dependent Insulinotropic Receptor (G-Protein ...

Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016

Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • April 2016
  • by Global Markets Direct

Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) ...

Plasminogen Activator Inhibitor-1 (Endothelial Plasminogen Activator Inhibitor or Serpin E1 or PAI-1) - Pipeline Review, H1 2016

Plasminogen Activator Inhibitor-1 (Endothelial Plasminogen Activator Inhibitor or Serpin E1 or PAI-1) - Pipeline Review, H1 2016

  • $ 3 500
  • Company report
  • April 2016
  • by Global Markets Direct

Plasminogen Activator Inhibitor-1 (Endothelial Plasminogen Activator Inhibitor or Serpin E1 or PAI-1) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Plasminogen Activator Inhibitor-1 ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.